Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASHYuki Kimura, Kazuaki Chayama, Koji Arihiro et al.|Journal of Gastroenterology|2010Cited by 160
Postprandial insulin secretion pattern is associated with histological severity in non‐alcoholic fatty liver disease patients without prior known diabetes mellitusYuki Kimura, Kazuaki Chayama, Hideyuki Hyogo et al.|Journal of Gastroenterology and Hepatology|2010Cited by 43
Clinical usefulness of glucose tolerance test in nonalcoholic fatty liver disease patients without overt diabetes mellitusYuki Kimura, Kazuaki Chayama, Koji Arihiro et al.|Kanzo|2010Cited by 1